Print

Print


Just watched a television show called "Frontiers of Medicine," which
included a segment on the renewal of interest in pallidotomies, as
evidenced by the work of Drs.. Richard Lehman and Evangelia Tzanakou of the
Robert Wood Johnson Medical Center in New Jersey.

The website that shows the text of this segment can not be referenced
easily by a URL, and I don't understand why.  Go to
http://www.frontiersofmedicine.com  then choose Search, and enter
Parkinson's.  The broadcast to which I refer is program #12, transcript #3.

The site is an interesting one to explore, as it is supported by the
Medtronic Foundation and has a number of Parkinsonian references.  Curious,
isn't it, that the manufacturers of Activa, the Deep Brain Stimulator,
would be pushing their "competition."

For those who do not have browsing capabilities, here is the text from this
show:

Show #12- Transcript #3
  Hosted By: LouisW. Sullivan, M.D.

  Parkinson's Disease

                      NARRATOR:
                      Parkinson's Disease is a neurological disorder that
                      slowly robs its sufferers of their quality of life.
It afflicts
                      between a million and a million-and-a-half American,
                      including some of our most prominent leaders,
                      entertainers and athletes. The cause of the disease is
                      unknown, but it leads to degeneration in the part of the
                      brain that produces dopamine.

                      Dopamine is a chemical that enables people to move
                      normally and smoothly; without enough of it, sufferers
                      experience rigidity, tremors, poor balance, slowness of
                      movement, and other debilitating symptoms. While there
                      are many drugs that can increase dopamine to help
                      control the disease's symptoms, they all lose
                      effectiveness over time. The most common drug, L-dopa,
                      appears to become ineffective after a decade or less of
                      use.

                      This leaves long-term sufferers with a difficult
decision:
                      Allow Parkinson's Disease to progressively control more
                      and more of their life, or undergo brain surgery. One
                      surgery that had fallen into disfavor but has recently
                      seen its popularity revived is pallidotomy. In this
                      operation, doctors go on a search-and-destroy mission
                      to locate the cells causing movement difficulties and
                      eliminate them. Once the cells are gone, so are the
                      symptoms.

                      NARRATOR:
                      The new popularity of pallidotomy comes from recent
                      advances that enable doctors to pinpoint more precisely
                      the location of the offending cell cluster. Dr. Richard
                      Lehman at Robert Wood Johnson University Hospital in
                      New Brunswick, New Jersey, has teamed up with Prof.
                      Evangelia Tzanakou from neighboring Rutgers University
                      to better address the targeting concerns. Professor
                      Tzanakou, who is a trained physicist, has come up with
                      a new, more accurate method to find the cells that are
                      responsible for a patient's symptoms. With an electrode
                      that is more traditionally used for measuring seismic
                      activity, she measures a patient's brain electroactivity.
                      When she finds a peak in the activity, she has found the
                      cluster that needs to be treated. The cluster is then
                      displayed on a 3-D model of the patient's brain that
                      shows the doctor where the cluster is located.

                      NARRATOR:
                      Dr. Lehman then uses radio waves to burn the cluster
                      and leave a lesion. Once the lesion has been made,
                      Professor Tzanakou takes another reading of the same
                      area. If the cluster has been properly destroyed, her
                      measurement will indicate zero activity for that cluster.
                      However, if there is significant residual
electroactivity, Dr.
                      Lehman will continue to make lesions until the cluster
                      has been eliminated. But because the new technique is
                      so accurate, Dr. Lehman is rarely required to make
                      multiple lesions.

                      NARRATOR:
                      The new procedure also allows the doctor to check the
                      outcome of the procedure immediately. This means that
                      Dr. Lehman can be positive that he has solved the
                      problem before he closes the patient's head. Professor
                      Tzanakou is hopeful that other doctors will adopt her
                      targeting method. Until other facilities become equipped
                      and trained to use her measurement software, she does
                      plan to offer her services via another form of
technology -
                      the Internet. Beginning this summer, she will take part
                      via the Internet in several pallidotomies scheduled
in the
                      United Kingdom. Doctor Tzanakou does have to keep
                      her schedule open for Dr. Lehman however; because of
                      the improved outcomes, Dr. Lehman have vowed not to
                      perform any operations without using Dr. Tzanakou's
                      measurements.

                      NARRATOR:While it might seem strange for a physicist
                      with a laptop computer to hold the key to a safer, more
                      accurate surgical procedure, it does show that when
                      great minds set out to solve medical problems, their
                      solutions will be on the frontiers of better medicine.